Mottolese M - Search Results

1

Human Mena protein, a serex-defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T-cell immune response.

Di Modugno F, Bronzi G, Scanlan MJ, Del Bello D, Cascioli S, Venturo I, Botti C, Nicotra MR, Mottolese M, Natali PG, Santoni A, Jager E, Nisticò P. Di Modugno F, et al. Among authors: mottolese m. Int J Cancer. 2004 May 10;109(6):909-18. doi: 10.1002/ijc.20094. Int J Cancer. 2004. PMID: 15027125 Free article.

2

The cytoskeleton regulatory protein hMena (ENAH) is overexpressed in human benign breast lesions with high risk of transformation and human epidermal growth factor receptor-2-positive/hormonal receptor-negative tumors.

Di Modugno F, Mottolese M, Di Benedetto A, Conidi A, Novelli F, Perracchio L, Venturo I, Botti C, Jager E, Santoni A, Natali PG, Nisticò P. Di Modugno F, et al. Among authors: mottolese m. Clin Cancer Res. 2006 Mar 1;12(5):1470-8. doi: 10.1158/1078-0432.CCR-05-2027. Clin Cancer Res. 2006. PMID: 16533770 Free article.

3

Breast cancer is associated with loss of the c-kit oncogene product.

Natali PG, Nicotra MR, Sures I, Mottolese M, Botti C, Ullrich A. Natali PG, et al. Among authors: mottolese m. Int J Cancer. 1992 Nov 11;52(5):713-7. doi: 10.1002/ijc.2910520508. Int J Cancer. 1992. PMID: 1385336

4

Low prevalence of selective human leukocyte antigen (HLA)-A and HLA-B epitope losses in early-passage tumor cell lines.

Giacomini P, Giorda E, Fraioli R, Nicotra MR, Vitale N, Setini A, Delfino L, Morabito A, Benevolo M, Venturo I, Mottolese M, Ferrara GB, Natali PG. Giacomini P, et al. Among authors: mottolese m. Cancer Res. 1999 Jun 1;59(11):2657-67. Cancer Res. 1999. PMID: 10363989

5

Host immunosurveillance contributes to the control of erbB-2 overexpression in HLA-A2-breast-cancer patients.

Nisticò P, Mottolese M, Cascioli S, Benevolo M, Del Bello D, Di Modugno F, Rubiu O, Gentile FP, Botti C, Venturo I, Natali PG. Nisticò P, et al. Among authors: mottolese m. Int J Cancer. 1999 Dec 22;84(6):598-603. doi: 10.1002/(sici)1097-0215(19991222)84:6<598::aid-ijc10>3.0.co;2-7. Int J Cancer. 1999. PMID: 10567905 Free article.

6

Polyclonal antibodies against gp185HER2 peptides: their putative role in the identification of a particular HER2 status in patients with breast cancer.

Di Modugno F, Buglioni S, Mottolese M, Bello DD, Cascioli S, Chersi A, Santoni A, Nisticò P. Di Modugno F, et al. Among authors: mottolese m. J Immunother. 2001 May-Jun;24(3):221-31. J Immunother. 2001. PMID: 11394499

7

Polyclonal Antibodies Against gp185HER2 Peptides: Their Putative Role in the Identification of a Particular HER2 Status in Patients With Breast Cancer.

Di Modugno F, Buglioni S, Mottolese M, Del Bello D, Cascioli S, Chersi A, Santoni A, Nisticò P. Di Modugno F, et al. Among authors: mottolese m. J Immunother (1991). 2001 May;24(3):221-231. J Immunother (1991). 2001. PMID: 11395637

8

Altered expression of FAS system is related to adverse clinical outcome in stage I-II breast cancer patients treated with adjuvant anthracycline-based chemotherapy.

Botti C, Buglioni S, Benevolo M, Giannarelli D, Papaldo P, Cognetti F, Vici P, Di Filippo F, Del Nonno F, Venanzi FM, Natali PG, Mottolese M. Botti C, et al. Among authors: mottolese m. Clin Cancer Res. 2004 Feb 15;10(4):1360-5. doi: 10.1158/1078-0432.ccr-1092-03. Clin Cancer Res. 2004. PMID: 14977837

9

Phenotypic changes of p53, HER2, and FAS system in multiple normal tissues surrounding breast cancer.

Mottolese M, Nádasi EA, Botti C, Cianciulli AM, Merola R, Buglioni S, Benevolo M, Giannarelli D, Marandino F, Donnorso RP, Venturo I, Natali PG. Mottolese M, et al. J Cell Physiol. 2005 Jul;204(1):106-12. doi: 10.1002/jcp.20275. J Cell Physiol. 2005. PMID: 15622519

10

Human Mena+11a isoform serves as a marker of epithelial phenotype and sensitivity to epidermal growth factor receptor inhibition in human pancreatic cancer cell lines.

Pino MS, Balsamo M, Di Modugno F, Mottolese M, Alessio M, Melucci E, Milella M, McConkey DJ, Philippar U, Gertler FB, Natali PG, Nisticò P. Pino MS, et al. Among authors: mottolese m. Clin Cancer Res. 2008 Aug 1;14(15):4943-50. doi: 10.1158/1078-0432.CCR-08-0436. Clin Cancer Res. 2008. PMID: 18676769 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

243 results

Search Page